Resources

Welcome to the Biointron Learning Center

Antibody Industry Trends Upcoming Events Webinars Case Studies Promotions Brochures Blog

Industry Trends

Biointron Insights: Antibody Industry Report (YTD December 2024 Insights, Trends & Analysis)

This report aims to explore the events and trends of the biopharmaceutical industry in 2024 (YTD December 2024). This year, 22 novel antibody drugs have been approved by at least one regulatory agency around the world.

Jan 01, 2025

Week 2, January 2025: Antibodies X PROTACs

Proteolysis targeting chimeras (PROTACs) are heterobifunctional molecules designed to degrade specific proteins by recruiting an E3 ubiquitin ligase to the target protein, leading to its ubiquitylation and subsequent degradation by the proteasome. This novel mechanism enables PROTACs to eliminate on

Jan 14, 2025

Read time: 3 mins

January 2024: Antibody Glycoengineering

According to Research and Markets, the global market for Fc and glycoengineered antibodies is projected to be worth US$38.8 billion in 2024. Over the next decade, the growth in opportunities for drug developers is expected to be driven by an increasing patient population and rising demand for these

Jan 07, 2025

Read time: 6 mins

Learn More

Upcoming Events

15th Annual World ADC – London 2025

Biointron is excited to announce our participation in the World ADC London 2025 Conference, set to take place March 3-6,···

Jan 03, 2025

NextGen Biomed Europe 2025

Biointron is delighted to announce our participation in the NextGen Biomed Europe 2025 Conference, happening on March 12···

Jan 03, 2025

CPHI JAPAN 2025

Biointron is thrilled to announce our participation in CPHI Japan 2025, one of Asia’s most influential pharmaceutical ev···

Jan 03, 2025

Learn More

Webinars

Biointron x Omics Bio Webinar: Accelerating Early Discovery through HTP and High-Speed Antibody Production

Jul 15, 2024

Biointron x Antibody Society Webinar: Accelerating Antibody Drug Discovery with Fully Human Antibody Mouse HUGO-Ab and High-Throughput Single B Cell S……

Jul 15, 2024

Biointron x AET US 2023 Webinar: Accelerating Early Discovery through HTP & High-Speed Antibody Production

Biointron's SVP of R&D, Lei Shi, PhD, discussed the processes of accelerating early discovery through HTP and high-speed antibody production during the Antibody Engineering & Therapeutics US 2023 conference in San Diego. Below is a summary of the talk.

Mar 21, 2024

Learn More

Case Studies

Stable Cell Line Generation

Case 1: Tag-Free Vaccine Protein. During the generation of stable cell lines, cells are selected and screened to identify clones that stably express t···

Mar 08, 2024

Afucosylated Antibodies

Biointron has developed our own CHOK1-Fut8KO expression platform for afucosylated antibodies.

Dec 15, 2023

Single B Cells: PD-1-Specific Antibody Screening

Biointron established a single-B cell antibody discovery platform based on microfluidic technology. Combined with our proprietary fast antibody expres···

Dec 15, 2023

Learn More